Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    Open Studies | Plasmin
Show Display Options
Rank Status Study
1 Not yet recruiting Anfibatide Treatment in STEMI Patients
Condition: ST Segment Elevation Myocardial Infarction
Interventions: Drug: placebo;   Drug: Anfibatide
2 Recruiting Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery
Conditions: Pregnancy Complications;   Hemorrhage
Interventions: Drug: tranexamic acid 1 g (TA1);   Drug: tranexamic acid 0.5 g (TA1/2);   Drug: Saline Solution (TA0)

Study has passed its completion date and status has not been verified in more than two years.